August 2017 FDA Recall Drug by Amphastar Pharmaceuticals, Inc.
D-1124-2017 - Crystallization

This Class II drug recall was voluntarily initiated by Amphastar Pharmaceuticals, Inc. on August 15, 2017 for the product Drug. The FDA reported the reason for recall as crystallization. The product was distributed in Distributed throughout the United States and the recall is currently terminated.

Recall Number: D-1124-2017

Reason for Recall
Crystallization: Particulate matter (Ketorolac Calcium Salt) was observed from several lots of retained samples.
Initiated
08-15-2017
Reported
09-06-2017
Quantity
637,810 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Amphastar Pharmaceuticals, Inc.
Distributed throughout the United States
Ketorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL single-dose vials, Rx only, Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA 91730, NDC 0548-9021-00

Batch or Lot Expiration Information

Lot# XI002A6, XI003A6, Exp 12/17; XI004G6, XI005G6, Exp 6/18; XI007H6, Exp 7/18; XI00816, XI00916, XI01016, XI01116, Exp 8/18; XI012J6, XI013J6, Exp 9/18; XI015K6, Exp 10/18; XI016L6, Exp 11/18; XL018A7, XI019A7, Exp 12/18; XI020B7, XI021B7, Exp 1/19; XI022C7, XI023C7, Exp 2/19; XI025D7, Exp 3/19.